implications of new nivolumab and ipililumab combination data in melanoma brain metastases
Published 5 years ago • 38 plays • Length 9:06Download video MP4
Download video MP3
Similar videos
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
6:21
new long-term data 'clearly favor' combination ipilimumab/nivolumab in melanoma
-
2:45
long-term outcomes of nivo vs. nivo/ipi in melanoma brain metastases: abc trial data
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
7:28
new data for immunotherapy in melanoma brain metastases
-
0:58
combination nivolumab and ipilimumab shows efficacy in advanced melanoma
-
0:49
brain metastases and survival evaluation in the secombit trial
-
2:29
immunotherapy combination offers hope for melanoma brain metastases
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
7:08
the value of ipi/nivo in treating metastatic melanoma
-
2:11
dr. long on rationale for nivolumab/ipilimumab in patients with melanoma who have brain mets
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
2:54
combining nivolumab and ipilimumab in patients with resected stage iv melanoma
-
3:16
melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better pfs
-
1:09
dr. patel on benefit of ipilimumab/nivolumab combo in high-grade neuroendocrine carcinoma
-
0:49
scandium 2: ihp with ipilimumab and nivolumab in uveal melanoma metastases
-
1:11
nivolumab/ipilimumab combination data promising in msi-h/dmmr mcrc
-
2:02
dr. jedd wolchok on concurrent ipilimumab and nivolumab in advanced melanoma
-
3:15
icon: chemotherapy combined with ipilimumab and nivolumab in metastatic hr breast cancer